NYSE - Delayed Quote USD

Nuvation Bio Inc. (NUVB)

2.6800 +0.0600 (+2.29%)
At close: April 26 at 4:00 PM EDT
2.7400 +0.06 (+2.24%)
After hours: April 26 at 7:53 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
99,822.0000
99,822.0000
119,734.0000
93,318.0000
43,551.0000
Operating Income
-99,822.0000
-99,822.0000
-119,734.0000
-93,318.0000
-43,551.0000
Net Non Operating Interest Income Expense
24,611.0000
24,611.0000
7,448.0000
2,963.0000
1,945.0000
Other Income Expense
-591.0000
-591.0000
8,087.0000
3,507.0000
-53.0000
Pretax Income
-75,802.0000
-75,802.0000
-104,199.0000
-86,848.0000
-41,659.0000
Net Income Common Stockholders
-75,802.0000
-75,802.0000
-104,199.0000
-86,848.0000
-41,659.0000
Diluted NI Available to Com Stockholders
-75,802.0000
-75,802.0000
-104,199.0000
-86,848.0000
-41,659.0000
Basic EPS
-0.35
--
-0.48
-0.44
-0.19
Diluted EPS
-0.35
--
-0.48
-0.44
-0.19
Basic Average Shares
218,880.0000
--
216,721.0000
197,887.0000
217,650.0550
Diluted Average Shares
218,880.0000
--
216,721.0000
197,887.0000
217,650.0550
Total Operating Income as Reported
-99,822.0000
-99,822.0000
-119,734.0000
-93,318.0000
-43,551.0000
Total Expenses
99,822.0000
99,822.0000
119,734.0000
93,318.0000
43,551.0000
Net Income from Continuing & Discontinued Operation
-75,802.0000
-75,802.0000
-104,199.0000
-86,848.0000
-41,659.0000
Normalized Income
-76,160.0000
-76,160.0000
-113,158.0000
-90,999.0000
-41,877.0000
Interest Income
24,611.0000
24,611.0000
7,448.0000
2,963.0000
1,945.0000
Net Interest Income
24,611.0000
24,611.0000
7,448.0000
2,963.0000
1,945.0000
EBIT
-99,822.0000
-99,822.0000
-119,734.0000
-93,318.0000
-43,551.0000
EBITDA
-99,600.0000
-99,600.0000
-119,535.0000
-93,134.0000
-43,448.0000
Reconciled Depreciation
222.0000
222.0000
199.0000
184.0000
103.0000
Net Income from Continuing Operation Net Minority Interest
-75,802.0000
-75,802.0000
-104,199.0000
-86,848.0000
-41,659.0000
Total Unusual Items Excluding Goodwill
358.0000
358.0000
8,959.0000
4,151.0000
218.0000
Total Unusual Items
358.0000
358.0000
8,959.0000
4,151.0000
218.0000
Normalized EBITDA
-99,958.0000
-99,958.0000
-128,494.0000
-97,285.0000
-43,666.0000
12/31/2020 - 8/26/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CTMX CytomX Therapeutics, Inc.
1.5900
-0.62%
 
NXTC NextCure, Inc.
1.3500
+4.65%
 
ALGS Aligos Therapeutics, Inc.
0.7820
-4.40%
 
ELYM Eliem Therapeutics, Inc.
3.9800
+17.40%
 
BCAB BioAtla, Inc.
2.5400
+12.89%
 
LYEL Lyell Immunopharma, Inc.
2.1700
-1.36%
 
RGLS Regulus Therapeutics Inc.
2.4200
+6.61%
 
BNTC Benitec Biopharma Inc.
6.90
0.00%
 
ASMB Assembly Biosciences, Inc.
12.65
-5.31%
 
KZR Kezar Life Sciences, Inc.
0.8049
+1.89%